Wider window for stroke drug

Stroke patients can benefit from treatment with alteplase even if they miss the drug's three-hour treatment window, research suggests.

But fast treatment remains patients' best hope of achieving recovery, researchers stressed.

The thrombolytic drug alteplase is currently licensed for use within three hours of an acute ischaemic stroke.

Researchers from the University of Heidelberg, Germany, looked at benefits for patients outside this window.

They randomised 821 patients presenting between three and 4.5 hours after onset of stroke to receive alteplase or placebo.

All endpoints studied showed benefits for a wide range of patients, but not all differences were statistically significant.

'Our results support the use of this thrombolytic drug in the extended period across a broad range of patient subgroups,' the researchers said.

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins


Already registered?

Sign in

Just published

GP consultation

GP practices delivering 150,000 extra appointments per day compared with 2019

GP practices in England delivered 150,000 more appointments per working day in the...

Surgeon looking at a monitor in an operating theatre

NICE recommends non-invasive surgical procedure to target obesity

NICE has said that a non-invasive weight loss procedure should be used by the NHS...

GP trainee

Two training posts deliver one full-time GP on average, report warns

Two training posts are needed on average to deliver a single fully-qualified, full-time...

Dr Fiona Day

How to flourish as a GP by learning from the good and the difficult

Leadership and career coach Dr Fiona Day explains how GPs can grow and develop from...

Unhappy older woman sitting at home alone

Low mood – red flag symptoms

Low mood is a common presentation in primary care and can be a sign of a mental health...


PCN to take on GMS practice contract in landmark move for general practice

A GP practice in Hertfordshire could become the first to be run directly by a PCN...